| 21/61 | US=110 / Câncer Ford JM, Kastan MB. DNA damage response pathways and cancer. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 139-52. ISBN 978-0-443-06695-5. DNA VIAS DANOS DE RESPOSTA E CANCER; TIPOS DE DANOS NO DNA; CONSEQUENCIAS DE DANOS AO DNA; TIPOS DE REPARO DO DNA. CONTRIBUICAO PARA O CANCER |
| 22/61 | US=35 / Biol/Mol D'Andrea AD. DNA repair pathways and human cancer. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 39-55. ISBN 978-1-4160-3703-3. VIAS DE REPARO DE DNA; CANCER HUMANO; DANOS AO DNA; INSTABILIDADE CROMOSSOMICA; METILACAO; SILENCIAMENTO GENICO; BIOMARCADORES |
| 23/61 | US=47 / Câncer Ackermann JM, El-Deiry WS. Targeting ATM/ATR in the DNA damage checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 93-116. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. SEGMENTACAO ATM/ATR; DANOS AO DNA; ATAXIA TELANGIECTASIA; RADIACAO IONIZANTE; FOSFORILACAO |
| 24/61 | US=47 / Câncer Kawabe T. Compounds that abrogate the G2 checkpoint. In: Dai W. Checkpoint responses in cancer therapy. New Jersey: Humana Press, 2008. p. 117-33. (Cancer Drug Discovery and Development) ISBN 978-1-58829-930-7. CICLO CELULAR; G1; G2; ONCOGENESE; TERAPIA DO CANCER; DANOS AO DNA; REPARO DO DNA; MUTACAO |
| 25/61 | US=58 / Câncer Krämer A. Centrosomes in checkpoint responses. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 53-67. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. CENTROSSOMAS NAS RESPOSTAS CHECKPOINT; CENTROSSOMA; DANOS NO DNA; CHECK-POINT; CHK1; PERICENTRIN; MICROCEFALINA; CDC25; SINDROME SECKEL; MICROCEFALIA; AMPLIFICACAO CENTROSSOMA; CATASTROFE MITOTICA |
| 26/61 | US=58 / Câncer Lee MH, Yeung SCJ, Yang HY. Interplay of 14-3-3 family of proteins with DNA damage-regulated molecules in checkpoint control. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 69-80. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. FAMILIA DE PROTEINAS COM 14-3-3; DANOS AO DNA; RESPOSTA CHECKPOINT; 14-3-3; AKT; MDM2; P53; DANOS NO DNA |
| 27/61 | US=58 / Câncer Kaina B, Roos WP, Christmann M. DNA damage response and the balance between cell survival and cell death. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 95-108. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; SOBREVIVENCIA CELULAR; MORTE CELULAR; CHECKPOINTS; CICLO CELULAR; RESPOSTA A DANOS DO DNA; REPARACAO DO ADN; P53; APOPTOSE; RECEPTORES DE MORTE; FAS; CAIXA ELETRONICO; ATR; DROGAS ANTICANCER |
| 28/61 | US=58 / Câncer Eastman A. The importance of p53 signaling in the response of cells to checkpoint inhibitors. In: Siddik ZH. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 189-98. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; PARADA DO CICLO CELULAR; P53; P21; CICLINA B; CHK1 INIBIDORES; UCN-01; INIBIDORES DA TOPOISOMERASE II; ANALOGOS DE NUCLEOSIDOS |
| 29/61 | US=58 / Câncer Siddik ZH. Targeting p21-dependent pathways for cell death in cancer therapy. In: ___. Checkpoint controls and targets in cancer therapy. New Jersey: Humana Press, 2008. p. 199-213. (Cancer Drug Discovery and Development Series) ISBN 978-1-60761-177-6. DANOS NO DNA; P21; CICLINA DEPENDENTE DE QUINASE; G1 RESPOSTA CHECKPOINT; PARADA DO CICLO CELULAR; TRANSATIVACAO; PARADA DO CICLO GENE |
| 30/61 | US=9 / Estatística Hertz-Picciotto I. Environmental epidemiology. In: Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia: Lippincott Wiilians & Wilkins, 2008. p. 598-619. ISBN 978-0-7817-5564-1. EPIDEMIOLOGIA AMBIENTAL; DOMINIO; AVALIACAO DA EXPOSICAO; PROJETOS DE ESTUDO; VIGILANCIA; AVALIACAO DE RISCO; DANOS AMBIENTAIS; SAUDE AMBIENTAL |
| 31/61 | US=9-B / Ginecologia Damario MA, Rock JA. Ectopic pregnancy. In: Rock JA, Jones III HW. TeLinde's operative gynecology. 10th ed. Philadelphia: Lippincott Williams & Wilkins, 2008. p. 798-24. ISBN 978-0-7817-7234-1. GRAVIDEZ ECTOPICA; DANOS TUBAL SECUNDARIA A INFLAMACAO; GRAVIDEZ ECTOPICA TUBARIA; GRAVIDEZ ECTOPICA. TRATAMENTO; GRAVIDEZ INTERSTICIAL; GRAVIDEZ INTERSTICIAL. TRATAMENTO; GRAVIDEZ ECTOPICA OVARIANA; GRAVIDEZ ECTOPICA ABDOMINAL; GRAVIDEZ ECTOPICA CERVICAL; GRAVIDEZ HETEROTOPICA; GRAVIDEZ ECTOPICA. IMUNOGLOBULINA RH |
| 32/61 | US=111 / Câncer Delia D, Buscemi G. Regulation of the cell cycle, cell cycle checkpoints, and cancer. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 36-46. ISBN 978-0-470-01852-1. REGULACAO DO CICLO CELULAR; CHECKPOINTS DO CICLO CELULAR; CANCER; DANOS AO DNA; APOPTOSE; SOBREVIVENCIA; RESPOSTAS TRANSCRICIONAIS; VIA DDR; ATM; ESTRESSE OXIDATIVO; MUTACOES SOMATICAS |
| 33/61 | US=111 / Câncer Gooderham NJ, Carmichael PL. Mechanisms of chemical carcinogenesis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 322-37. ISBN 978-0-470-01852-1. CANCER; QUIMICOS; MECANISMOS DE CARCINOGENESE QUIMICA; METABOLISMO DA CARCINOGENESE QUIMICA; DANOS AO DNA; MUTACAO |
| 34/61 | US=111 / Câncer Phillips DH. The formation of DNA adducts. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 338-50. ISBN 978-0-470-01852-1. CANCER; FORMACAO DE ADUTOS DE DNA; DANOS AO DNA; CARCINOGENESE; CARCINOGENESE QUIMICO |
| 35/61 | US=35 / Câncer Steensma DP. Molecular foundations of AML pathogenesis and physiology: the DNA damage response, DNA repair, and AML. In: Karp JE. Acute myelogenous leukemia. New Jersey: Humana Press, 2007. p. 97-131. (Contemporary Hematology) ISBN 978-1-58829-621-4. LEUCEMIA MIELOGENA AGUDA; RESPOSTA DE DANO DO DNA; REPARO DE DNA; RECONHECIMENTO DOS DANOS DO DNA; REPARO POR EXCISAO DE BASE; REPARO POR EXCISAO DE NUCLEOTIDEOS; RECOMBINACAO HOMOLOGA; ANEMIA DE FANCONI; SINDROME DE BLOOM; FAMILIA RECQ HELICASES; SINDROMES HEREDITARIAS; ATAXIA-TELANGIECTASIA; SINDROME DE QUEBRA DE NIJMEGEN; SINDROME DE SECKEL; PROTEINA NIBRIN |
| 36/61 | US=82 / Biol/Mol Schulz WA. DNA damage and DNA repair. In: ___. Molecular biology of human cancers: an advanced student's textbook. New York: Springer, 2007. p. 47-70. ISBN 978-1-4020-6559-0. DANOS NO DNA; REPARO DO DNA; EXCISAO DE BASES; REPARO POR EXCISAO DE NUCLEOTIDEOS; REPARACAO CROSSLINK; SUSCETIBILIDADE AO CANCER |
| 37/61 | US=92 / Biol/Mol Ianzini F, Mackey MA. Apoptosis and alternative modes of cell death: mitotic catastrople. In: Gewirtz DA, Holt SE, Grant S. Apoptosis, senescence and cancer. 2 ed. New Jersey: Humana Press, 2007. p. 73-91. (Cancer Drug Discovery and Development) ISBN 978-1-58829-527-9. CATASTROFE MITOTICA; REGULACAO DO CICLO CELULAR; CICLINA B1; CELULAS ENDOPOLYPLOID; MITOSE; MEISIS; CARCINOGENESE; PROGRESSAO TUMORAL; RETARDADA DANOS NO DNA; SPCC |
| 38/61 | US=10 / Biol/Mol Pelengaris S, Khan M. Genetic instability, chromosomes, and repair. In: ___. The molecular biology of cancer. Oxford: Blackwell, 2006. p. 296-325. ISBN 978-1-4051-1814-9. INSTABILIDADE GENETICA; CROMOSSOMOS; REPARAR; TIPOS DE INSTABILIDADE GENEMICA; RESPOSTA A DANOS NO DNA; SENSOR DE DANOS NO DNA; REPARACAO DE DANOS NO DNA; CHECKPOINTS; MICROSSATELITES; MINISATELITES; SUMO; REPARO DO DNA; SINDROMES DE SUSCEPTIBILIDADE AO CANCER; INSTABILIDADE GENOMICA; CANCER DE COLON; CANCER DE MAMA; GENES BRCA |
| 39/61 | US=14 / Fisioterapia Dutton M. Conceito de função. In: ___. Fisioterapia ortopédica: exame, avaliação e intervenção. Porto Alegre: Artmed, 2006. p. 139-56. ISBN 85-363-0727-7. |
| 40/61 | US=47 / Imagem Niemierko A. Biological aspects of IMRT planning and delivery. In: Bortfeld T, Schmidt-Ulrich R, de Neve W, Wazer DE. Image-Guided IMRT. Berlin: Springer, 2006. p. 91-6. ISBN 3-540-20511-X. RADIOTERAPIA DE INTENSIDADE MODULADA; TECNICAS DE ENTREGA; ASPECTOS BIOLOGICOS; REPARACAO DE DANOS SUBLETAIS; CANCER INDUZIDO POR RADIACAO; ENTREGA DE DOSE DE REFORCO |